Qualitative Reasoning at Multiple Resolutions
Abstract
This phase 2 trial showed that TZT-1027 administered on days 1 and 8 of a 21-day cycle had no anticancer activity. Further development of TZT-1027 in patients with previously treated NSCLC is not warranted.
Cite
Text
Murthy. "Qualitative Reasoning at Multiple Resolutions." AAAI Conference on Artificial Intelligence, 1988. doi:10.1016/j.lungcan.2006.10.002Markdown
[Murthy. "Qualitative Reasoning at Multiple Resolutions." AAAI Conference on Artificial Intelligence, 1988.](https://mlanthology.org/aaai/1988/murthy1988aaai-qualitative/) doi:10.1016/j.lungcan.2006.10.002BibTeX
@inproceedings{murthy1988aaai-qualitative,
title = {{Qualitative Reasoning at Multiple Resolutions}},
author = {Murthy, Seshashayee S.},
booktitle = {AAAI Conference on Artificial Intelligence},
year = {1988},
pages = {296-300},
doi = {10.1016/j.lungcan.2006.10.002},
url = {https://mlanthology.org/aaai/1988/murthy1988aaai-qualitative/}
}